The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Open accessAbstract
BACKGROUND AND METHODS: The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether cholesterol lowering induced by the partial ileal bypass operation would favorably affect overall mortality or mortality due to coronary heart disease. The study population consisted of 838 patients (417 in the control group and 421 in the surgery group), both men (90.7 percent) and women, with an average age of 51 years, who had survived a first myocardial infarction. The mean follow-up period was 9.7 years. RESULTS: When compared with the control group at five years, the surgery group had a total plasma cholesterol level 23.3 percent lower (4.71 +/- 0.91 vs. 6.14 +/- 0.89 mmol per liter [mean +/- SD]; P less than 0.0001), a low-density lipoprotein cholesterol level 37.7 percent lower (2.68 +/- 0.78 vs. 4.30 +/- 0.89 mmol per liter; P less than 0.0001), and a high-density lipoprotein cholesterol level 4.3 percent higher (1.08 +/- 0.26 vs. 1.04 +/- 0.25 mmol per liter; P = 0.02). Overall mortality and mortality due to coronary heart disease were reduced, but not significantly so (deaths overall [control vs. surgery], 62 vs. 49, P = 0.164; deaths due to coronary disease, 44 vs. 32, P = 0.113). The overall mortality in the surgery subgroup with an ejection fraction greater than or equal to 50 percent was 36 percent lower (control vs. surgery, 39 vs. 24; P = 0.021). The value for two end points combined--death due to coronary heart disease and confirmed nonfatal myocardial infarction--was 35 percent lower in the surgery group (125 vs. 82 events; P less than 0.001). During follow-up, 137 control-group and 52 surgery-group patients underwent coronary-artery bypass grafting (P less than 0.0001). A comparison of base-line coronary arteriograms with those obtained at 3, 5, 7, and 10 years consistently showed less disease progression in the surgery group (P less than 0.001). The most common side effect of partial ileal bypass was diarrhea; others included occasional kidney stones, gallstones, and intestinal obstruction. CONCLUSIONS: Partial ileal bypass produces sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease. The role of this procedure in the management of hypercholesterolemia remains to be determined. These results provide strong evidence supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, each 1-mmol/L reduction in LDL-C was associated with an RR of 0.75 (95% CI, 0.66-0.86;P = .002)in major vascular events”
From Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis (2016) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Practical Nonparametric Statistics
Groggel, D. J., & Conover, W. J. (2000) · Technometrics · doi:10.2307/1271101 · Cited by 11,076
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,091
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Research works printed but not linked: 29
- 10.1001/jama.256.20.2823 · DOI · Paper page
- Leren, 1966, Acta Med Scand Suppl, 466, 1
- 1968, Lancet, 2, 693
- Frantz, 1975, Circulation, 52, II-4
- 10.1001/jama.231.4.360 · DOI
- 10.1001/jama.251.3.351 · DOI · Paper page
- 10.1001/jama.257.23.3233 · DOI
- Buchwald H. Intestinal bypass for hypercholesterolemia. In: Nyhus LM, Baker RJ, eds. Mastery of surgery. Vol. 3. Boston: Little, Brown, 1984:901–7.
- Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: W.B. Saunders, 1990:1799–819.
- Schouten, 1986, Artery, 13, 240
- 1959, Stat Bull Metrop Life Insur Co, 40, 1
- Bruce, 1971, Ann Clin Res, 3, 323
- National Heart and Lung Institute, Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75–628.)
- 1970, Bull World Health Organ, 43, 891
- Mantel, 1966, Cancer Chemother Rep, 50, 163
- Matts, Controlled Clin Trials
- Campos, 1987, Surgery, 102, 424
- Campos, 1988, Curr Surg, 45, 380
- Campos, 1988, Surg Forum, 39, 193
- Addison, 1851, Guys Hosp Rep, 2, 267
- Ignatovski, 1908, Izviest Imp Voyenno-med Akad S Petersb, 16, 154
- Anitschkow, 1913, Centralbl Allg Pathol Pathol Anat, 24, 1
- Wacker, 1913, Münchener Med Wochenschr, 60, 2097
- European Coronary Surgery Study Group, 1982, Lancet, 2, 1173
- Buchwald, 1965, Surgery, 58, 22
- Scott, 1967, Surg Gynecol Obstet, 125, 3
- Buchwald, 1963, Circulation, 28, II-649
- Moore, 1969, Surgery, 65, 98
- Buchwald, Ann Surg
Cited by
Sorted by citations
Items 501–600 of 1,000
Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence
Mooradian, A. D. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0199-7 · Cited by 15
Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease
Ullrich, H., Lackner, K. J., & Schmitz, G. (1996) · Transfusion Science · doi:10.1016/s0955-3886(96)00049-5 · Cited by 14
Merz, C. N. B., Felando, M. N., & Klein, J. (1996) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199603000-00006 · Cited by 14
Secondary prevention of coronary heart disease
Zafari, A. M., & WENGER, N. K. (1998) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(98)90103-4 · Cited by 13
Correlation of coronary with peripheral arterial stenosis
Karnegis, J. N., Matts, J. P., Tuna, N., Hunter, D. W., & Amplatz, K. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90006-3 · Cited by 14
Self-citationKramsch, D. M. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)00249-0 · Cited by 15
Prevention and Regression of Coronary Atherosclerosis
Montague, T. J., Tsuyuki, R. T., Burton, J. R., Williams, R., Džavík, V., & Teo, K. K. (1994) · CHEST Journal · doi:10.1378/chest.105.3.718 · Cited by 14
Vogel, R. A. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90941-q · Cited by 14
Encouraging appropriate treatment for familial hypercholesterolemia
Hopkins, P. N. (2010) · Clinical Lipidology · doi:10.2217/clp.10.22 · Cited by 14
Deaths from Injury, Violence, and Suicide in Secondary Prevention Trials of Cholesterol Lowering
(1991) · New England Journal of Medicine · doi:10.1056/nejm199112193252516 · Cited by 14
de Feyter, P. J., Vos, J., Reiber, J. H. C., & Serruys, P. W. J. C. (1993) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1854-5_14 · Cited by 14
Hipercolesterolemia familiar: artículo de revisión
Merchán, A., Ruiz, Á. J., Campo, R., Prada, C. E., Toro, J. M., Sánchez, R., Gómez‐Mesa, J. E., Jaramillo, N. I., Molina, D. I., Vargas‐Uricoechea, H., et al. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.05.002 · Cited by 18
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/ simvastatin combination
Neal, R. C., & Jones, P. H. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.1.31 · Cited by 13
Eisenberg, T. A., & Wells, M. T. (2008) · Journal of Empirical Legal Studies · doi:10.1111/j.1740-1461.2008.00132.x · Cited by 13
Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer?
Nicholls, S. J., Tuzcu, E. M., & Nissen, S. E. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0032-5 · Cited by 13
The proving of the lipid hypothesis
Thompson, G. R. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00002 · Cited by 13
Regression of femoral atherosclerosis.
OLSSON, A. G. (1991) · Circulation · doi:10.1161/01.cir.83.2.698 · Cited by 13
Risk Reduction and the Program on the Surgical Control of the Hyperlipidemias
Buchwald, H. (2001) · Circulation · doi:10.1161/01.cir.104.9.e47 · Cited by 13
Self-citationBarter, P. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01961-7 · Cited by 13
Dawson, P. A. (2015) · Digestive Diseases · doi:10.1159/000371691 · Cited by 12
Pharmacotherapy in familial hypercholesterolemia - Current state and emerging paradigms
Kallapur, A. S., & Sallam, T. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.12.011 · Cited by 14
Coronary atherosclerosis stabilization: an achievable goal
Maher, V. M. G. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05732-3 · Cited by 12
Mack, W. J., Azen, S. P., Dunn, M. E., & Hodis, H. N. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00181-x · Cited by 12
Friedman, C., Romeo, D., & Hinton, S. S. (1997) · American Journal of Medicine · doi:10.1016/s0002-9343(97)00468-3 · Cited by 14
K, K. S., Panda, D. S., Swain, S. R., B, B. B., & K, T. D. (2007) · Cited by 12
Modern Management of Acute Myocardial Infarction
Reeder, G. S., & Gersh, B. J. (2000) · Current Problems in Cardiology · doi:10.1067/mcd.2000.109091 · Cited by 12
Buchwald, H., Campos, C. T., Boen, J., Nguyen, P., Williams, S. E., Lau, J., & Chalmers, T. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00007 · Cited by 12
Self-citationFor personal use. Only reproduce with permission from The Lancet.
Jung, J. H., Min, P., Moon, Y. J., Heum, W., & Shim (2004) · Cited by 12
The Effect of Noncritical Coronary Artery Disease on Long-Term Survival
Crenshaw, J. H., Sullivan, J. M., Ramanathan, K. B., Mirvis, D. M., El-Zeky, F., & Zwaag, R. V. (1995) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199507000-00005 · Cited by 12
LESSONS FROM CORONARY ATHEROSCLEROSIS "REGRESSION" TRIALS
Waters, D. D. (1996) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70259-9 · Cited by 10
Katsuki, S., Matoba, T., Akiyama, Y., Yoshida, H., Kotani, K., Fujii, H., Harada‐Shiba, M., Ishibashi, Y., Ishida, T., Ishigaki, Y., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64119 · Cited by 11
National Asthma Education and Prevention Program 2020 Guidelines: What’s Important for Primary Care
Murphy, M. (2021) · The Journal of Family Practice · doi:10.12788/jfp.0219 · Cited by 14
Verma, D. R., & Brinton, E. A. (2014) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0741 · Cited by 11
Lees, R. S., Holmes, N. N., Stadler, R. W., Ibrahim, S. F., & Lees, A. M. (1996) · Journal of Clinical Apheresis · doi:10.1002/(sici)1098-1101(1996)11:3 · Cited by 11
Low Density Lipoprotein Cholesterol and Coronary Heart Disease – Lower is Better
Hans-Willi, P. D. M. B. (2005) · European Cardiology Review · doi:10.15420/ecr.2005.18 · Cited by 11
Gebauer, K., & Reinecke, H. (2018) · VASA · doi:10.1024/0301-1526/a000689 · Cited by 11
Surgery for obesity in older women
Miller, M. E., & Kral, J. G. (2008) · Menopause international · doi:10.1258/mi.2008.008028 · Cited by 11
Is atherosclerotic vascular disease related to a high-fat diet?
Weintraub, W. S. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00541-3 · Cited by 12
Rallidis, L., Papageorgakis, N., Megalou, A., Exadactylos, N., Tsitouris, G., & Papasteriadis, E. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0770 · Cited by 12
Gotto, A. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90226-7 · Cited by 11
Rees, A., Lavie, C., & Pepine, C. (1993) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-3516-4_12
Does cholesterol lowering increase non-illness-related mortality?
Muldoon, M. F., Manuck, S. B., & Matthews, K. A. (1991) · PubMed · Cited by 11
Træden, U., Holm, L., Sandström, B., Andersen, P., & Jarden, M. (1998) · Public Health Nutrition · doi:10.1079/phn19980044 · Cited by 11
Simons, L. A. (1993) · Clinical Cardiology · doi:10.1002/clc.4960160406 · Cited by 11
Cholesterol and coronary disease —Outstanding questions
Oliver, M. F. (2004) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00054559
Ileal Effect on Blood Glucose, HbA1c, and GLP-1 in Goto-Kakizaki Rats
Buchwald, H., Menchaca, H. J., Michalek, V. N., & Bertin, N. T. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1307-x · Cited by 10
Self-citationCholesterol, Atherosclerosis and Coronary Disease in the UK, 1950–2000, vol. 27.
Reynolds, L., & Em, T. (2006) · UCL Discovery (University College London) · Cited by 10
Clinical Positioning of HMG-CoA Reductase Inhibitors in Lipid Management Protocols
Cziraky, M. J. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814003-00004 · Cited by 10
Manifestaciones hepatobiliares en la enfermedad inflamatoria intestinal
Herruzo, J. A. S., & Solís‐Muñoz, P. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007000900008 · Cited by 10
Ray, K. K., & Cannon, C. P. (2005) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/01.hpc.0000154979.98731.5d · Cited by 10
Karnegis, J. N., Matts, J. P., Tuna, N., & Amplatz, K. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90514-i · Cited by 10
Self-citationClinical Outcomes Associated with Pharmacist Involvement in Patients with Dyslipidemia
Cross, L. B., & Franks, A. S. (2005) · Disease Management & Health Outcomes · doi:10.2165/00115677-200513010-00004 · Cited by 10
Signorelli, S. S., Pino, L. D., Fichera, G., Celotta, G., Pennisi, G., Marchese, G., Costa, M. P., Fallico, R., Torrisi, B., & Virgilio, V. (2004) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2004.02.007 · Cited by 10
Black, D. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02325-6 · Cited by 10
Pathophysiology of Atherosclerosis
Kumar, A. G., & Ballantyne, C. M. (1998) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5715-9_1 · Cited by 10
Fruchart, J., & Packard, C. J. (1997) · Current Medical Research and Opinion · doi:10.1185/03007999709113334 · Cited by 10
Cholesterol and Mortality: What Can Meta-Analysis Tell Us?
Gordon, D. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1959-1_42 · Cited by 9
Drug and alternative therapies for hyperlipidemia
Stein, E. A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90156-2 · Cited by 10
Menchaca, H. J., Michalek, V. N., Rohde, T. D., & Hirsch, A. T. (2014) · Cited by 10
Enhanced LDL-C reduction: lower is better. Does it matter how?
Viljoen, A., & Wierzbicki, A. S. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01721.x · Cited by 10
Kreisberg, R. A. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90112-3 · Cited by 9
Serum lipid profiles and the presence of yellow plaque in coronary lesions in vivo.
Kitamura, K., Mizuno, K., Miyamoto, A., & Nakamura, H. (1997) · American Journal of Cardiology · doi:10.1016/s0002-9149(96)00840-5 · Cited by 7
Reckless, J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200008000-00002 · Cited by 49
Ray, K. K., & Cannon, C. P. (2007) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-007-0050-1 · Cited by 9
Evaluation of the cost-effectiveness of evolocumab in the FOURIER study: a Canadian analysis
Lee, T. C., Kaouache, M., & Grover, S. A. (2018) · CMAJ Open · doi:10.9778/cmajo.20180011 · Cited by 9
Semenkovich, C. F., Goldberg, A. C., & Goldberg, I. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00037-x · Cited by 14
McKenney, J. M., Ganz, P., Wiggins, B. S., & Saseen, J. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50026-3 · Cited by 10
Age-Related Changes Affecting Atherosclerotic Risk
Spagnoli, L. G., Mauriello, A., Orlandi, A., Sangiorgi, G., & Bonanno, E. (1996) · Drugs & Aging · doi:10.2165/00002512-199608040-00004 · Cited by 9
Reamy, B. V., & Thompson, P. D. (2004) · Current Sports Medicine Reports · doi:10.1249/00149619-200404000-00004 · Cited by 9
Cholesterol in patients with coronary heart disease
Bloomfield, H. E. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02599922 · Cited by 9
Quantitative coronary cineangiography for the study of atherosclerosis
Brunt, J. N. H., Watts, G. F., Lewis, B., Smith, L., & COLTART, D. J. (1995) · Medical Engineering & Physics · doi:10.1016/1350-4533(95)97315-g · Cited by 9
The Rationale for Intervention to Reduce the Risk of Coronary Heart Disease
Rippe, J., Angelopoulos, T., & Zukley, L. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827606292859 · Cited by 11
Effect of olsalazine on sodium-dependent bile acid transport in rat ileum
Chawla, A., Karl, P. I., Reich, R. N., Narasimhan, G., Michaud, G. A., Fisher, S. E., & Schneider, B. L. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064181 · Cited by 9
Toutouzas, P. K., & Richter, D. J. (2008) · Angiology · doi:10.1177/0003319708321748 · Cited by 9
EZETIMIBE IN HYPERCHOLESTEROLAEMIA
Farnier, M. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11333.x · Cited by 9
Comparative economic data regarding lipid-lowering drugs
Schwartz, J. S. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70440-0 · Cited by 9
Effects of statins on carotid disease and stroke
Crouse, J. R. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00009 · Cited by 9
Short- and long-term complications after living donor ileal resection
Wu, G. S., Liu, C., Zhou, X., Zhao, L., Zhang, W., Wang, M., Zhao, Q., & Liang, T. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17193 · Cited by 8
Individualized lipid-lowering therapy to further reduce residual cardiovascular risk
Weingärtner, O., Lütjohann, D., Plösch, T., & Elsässer, A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.016 · Cited by 8
Partial ileal bypass affords protection from onset of type 2 diabetes
Buchwald, H., Oien, D. M., Schieber, D. J., Bantle, J. P., & Connett, J. E. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.01.025 · Cited by 8
Self-citationLipoprotein Metabolism and the Treatment of Lipid Disorders
Freeman, M. W., & Walford, G. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00041-x · Cited by 10
Antilipidemic Drug Therapy Today and in the Future
Kramer, W. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_15 · Cited by 8
Myocardial infarction and percent arteriographic stenosis of culprit lesion
Buchwald, H., Hunter, D., Tuna, N., Williams, S. E., Boen, J. R., Hansen, B. J., Titus, J. L., & Campos, C. T. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00049-5 · Cited by 8
Self-citationGuyton, J. R., & Goldberg, A. C. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50027-5 · Cited by 8
The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst
Shafiq, N., Malhotra, S., Pandhi, P., & Grover, A. (2005) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-4-3 · Cited by 8
Drugs for treatment of patients with high cholesterol blood levels and other dyslipidemias
Bays, H. E., & Dujovne, C. A. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7156-3_2 · Cited by 8
Cardiovascular Disease Prevention Research at the National Heart, Lung, and Blood Institute
Simons‐Morton, D. G., & Cutler, J. A. (1998) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(97)00057-3 · Cited by 8
Unresolved issues in early trials of cholesterol lowering
LaRosa, J. C. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80464-0 · Cited by 8
Fitch, L. L., Buchwald, H., Matts, J. P., Johnson, J. W., Campos, C. T., & Long, J. M. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90311-9 · Cited by 8
Self-citationForecasting patient outcomes in the management of hyperlipidemia.
Brier, K. L., Tornow, J. J., Ries, A., Weber, M. P., & Downs, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.6.569 · Cited by 8
A clinical overview of dyslipidemias: Treatment strategies
Jones, P. H. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90050-l · Cited by 8
Miettinen, T. A., & Strandberg, T. E. (1992) · Annals of Medicine · doi:10.3109/07853899209148332 · Cited by 8
Current concepts in secondary prevention after acute myocardial infarction
Mehta, R. H., Bossone, E., & Eagle, K. A. (2000) · Herz · doi:10.1007/bf03044123 · Cited by 8
Weintraub, W., Wenger, N. K., Parthasarathy, S., & Brown, W. V. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00270-3 · Cited by 8
Crouse, J. R., & Furberg, C. D. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2333 · Cited by 8
Nonpharmacologic Approaches for the Treatment of Hyperlipidemia
Kermani, T. A., & Frishman, W. H. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000137736.74836.dd · Cited by 7
Medical and Surgical Obesity Treatments and Atherosclerosis: Mechanisms beyond Typical Risk Factors
Bostrom, J., Mottel, B. H., & Heffron, S. P. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00961-0 · Cited by 7
Primary Prevention of CVD with Aspirin: Benefits vs Risks
Weisman (2021) · The Journal of Family Practice · doi:10.12788/jfp.0222 · Cited by 7
Kapera, O., Xie, L., Marroquín, E. M., Ngenge, S., Mathew, M. S., Almandoz, J. P., Schellinger, J. N., Kukreja, S. S., Schneider, B. E., McAdams, C. J., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06456-y · Cited by 7
Beneficio clínico de las estatinas: ¿hemos cubierto todo el espectro?
Badimón, L., & Vilahur, G. (2011) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(11)12002-6 · Cited by 7
Metadata
- Authors
- Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hansen, B. J., Tuna, N., Karnegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., & Chalmers, T. C.
- Affiliations
- University of Minnesota (US)
- University of Southern California (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-10-04
- Volume
- 323
- Issue
- 14
- Pages
- 946-955
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331959986
- Cited by
- 1,001
- References
- 58
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 20 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 22 · 2015: 15 · 2014: 17 · 2013: 12 · 2012: 17
- FWCI
- 84.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- partial ileal bypass, hypercholesterolemia, coronary artery disease, mortality, myocardial infarction, cholesterol lowering, LDL cholesterol, HDL cholesterol, first myocardial infarction, coronary artery bypass grafting, ejection fraction, long-term outcomes, nonfatal myocardial infarction
- MeSH terms
- Adult, Coronary Disease, Electrocardiography, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hyperlipidemias, Jejunoileal Bypass, Lipids, Male, Middle Aged, Ultrasonography, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review